Immunoluminometric assay for copeptin measurement in cerebrospinal fluid: Technical aspects and pilot study.

CONCLUSIONS: This assay provides to best of our knowledge for the first time initial ranges values of CSF copeptin for patients without acute neurological disease and in patients with aSAH. Thus, it opens new doors to develop further calculations and relationships between diseases biomarker and outcome prediction.
PMID: 30194934 [PubMed - as supplied by publisher]

Source: International Journal of Clinical Chemistry - September 5, 2018 Category: Chemistry Authors: Mindt S, Andrade-Barazarte H, Tokhi U, Ludtka C, Neumaier M, Hänggi D Tags: Clin Chim Acta Source Type: research